Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

  1. Durán-Martínez, M.
  2. Azriel, S.
  3. Doulatram-Gamgaram, V.K.
  4. Moreno-Pérez, Ó.
  5. Pinés-Corrales, P.J.
  6. Tejera-Pérez, C.
  7. Merino-Torres, J.F.
  8. Brito-Sanfiel, M.
  9. Chico, A.
  10. Marco, A.
  11. García-Fernández, E.
  12. Martínez-Montoro, J.I.
Aldizkaria:
Diabetes and Metabolism

ISSN: 1878-1780,  1262-3636

Argitalpen urtea: 2024

Alea: 50

Zenbakia: 1

Mota: Artikulua

DOI: 10.1016/J.DIABET.2023.101501 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus